Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • InkRevenue Launches an AI-Driven Influencer Marketing Tool to Cut Execution Chaos Business
  • Fabtech Technologies Limited Announces Q4 and FY26 Results Reinforces Strategic Positioning as a Global Life science Infrastructure Platform Business
  • Chandan Healthcare Secures Long-Term MRI Tender in Haryana; Strengthens Government Diagnostics Portfolio Business
  • Manoj Jewellers Limited IPO Opens On 5th May 2025, Closes on 7th May 2025 Business
  • Surat’s First Event Conclave: A Bold Leap That Could Ignite Innovation in Event Industry Business
  • GV Sanjay Reddy Breaks It Down: Where India’s Solar Targets Stand in 2026 Business
  • IIPM’s Dr. Arindam Chaudhuri to take Entrepreneurial education to every household Business
  • SEPC Bags Massive Rs 673 Crore SAIL Expansion Project; Reinforces Position in Industrial Infrastructure Business

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • Skin Barrier Repair for Indian Skin: A Dermatology-First, Ingredient-Science Approach Health
  • Doctor’s Day Special: Best Cardiologists’ Insights on Heart Attacks in Young Adults & Prevention Health
  • Narayana Health’s Ground breaking Docu-Series “InsidER” Surpasses 100 Million Streams Health
  • Promea’s Vision For Blood Glucose Meter Powered By Mr. Pavan Chandra Nagoor Health
  • Dr. Sarita Sukhija Presents: The Art of Vaginal Tightening – A Guide by the Guiding Light Behind Myra IVF Health
  • Perzea Launch by Hetero Healthcare and Enzene Supports India’s Vision of Accessible Cancer Care Health

Recent Posts

  • How Officebing Is Positioning Itself as a Workspace Partner for India’s Growing GCC Ecosystem
  • Shyam Dhani Industries Limited Unveils 4-Pronged Growth Strategy; Aims to Achieve ₹300 Cr Turnover Over the Next Three Years
  • Doctors Dr. Surupa Sharma and Dr. Anupam Sharma Bring Midlife Conversations to Light Through Menopause and Andropause
  • AI Could Power 70% of Mumbai Home Searches by 2030; Broker Productivity May Double, Reports Palladian Partners Advisory Ltd.
  • Yuthika Expands Presence Across Hair Color, Skincare and Personal Care Categories

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Thirty young authors of India get a forum to showcase literary talent at the Muskaan Litfest for Child Authors  Business
  • A Fusion of Tradition and Modernity: Shobhini By Tini Komal’s Festive Collection Launches Today Business
  • Apollo Cancer Centre Hyderabad Felicitated Bone Cancer Survivors for Their Grit and Determination Health
  • Tronado Goes live on Top Cryptocurrency Exchanges Business
  • How The StartupLab Is helping startup Founders in Business Growth Business
  • Sree Metaliks (SML) Adopts Ladle Refining Furnace Method to Enhance Product Quality   Business
  • Star Housing Finance Limited Raises $2.7 Mn Equity to Augment the Net Worth and Build Scale in Rural Geographies Business
  • Definite Success Classes Celebrates Unprecedented NEET 2023 Outcomes in Bhopal  Education

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme